ONKION

Onkion is a Biotechnology venture active in creating innovative therapeutics focused in Onco-Channelopathies... Onkion SA is developing humanized monoclonal antibodies and antibody fragments capable to block Calcium and Potassium Channel-derived malignancies which can then stop the oncogenic re-programming when used alone or in combination with Standard of Care (SoC) therapeutics.

Also known as: Onkion SA

Primary location: Epalinges Switzerland